Skip to main content
Premium Trial:

Request an Annual Quote

Large Scale Biology Builds Manpower for Business Development

NEW YORK, June 20 - Large Scale Biology has expanded its business development team, creating two new executive positions, the company said Wednesday. 

Pieter Bax, who joined LSBC earlier this year, will serve as senior vice president for corporate development, and Guy della-Cioppa, formerly vice president for genomics, will serve as vice president for business development.

In addition, Manfred Scholz recently joined the company as senior director for business development.

LSBC said in a statement that the new appointments were geared to drumming up awareness of the company's technology and to encouraging new partnerships.

Before joining LSBC, Bax served as vice president of the biopharmaceutical development division of SRI International, a consulting firm, and previously worked as vice president for business development and product planning at Corvas International, a biotechnology firm based in San Diego.

Della-Cioppa has served as vice president for genomics at LSBC since 1989. During his tenure, he managed LSBC's business relationship with Dow Chemical and Dow AgroSciences, and in his new business development position, he will focus on establishing new business alliances, the company said.

Scholz will be located at LSBC's proteomics facility in Germantown, Md. Prior to joining LSBC, he worked at Boston Medical Consultants, where he provided strategic planning and market forecasting for in vitro diagnostics, histopathology, SNP genotyping and other genomics and proteomics companies.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.